Sponsor pipeline

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla clinical trial pipeline

Get alerts when Fundación Pública Andaluza para la gestión de la Investigación en Sevilla's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
4
Phase 3
2
Phase 4
2
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 12

Acute Myeloid Leukemia (AML) (2) · Leukemia (2) · Myelodysplastic Syndromes (MDS) (2) · Dementia (1) · Depression (1) · Heart Disease (1) · Huntington's Disease (1) · Multiple Myeloma (1) · NASH / MASH (1) · Obesity (1)

Get alerts when Fundación Pública Andaluza para la gestión de la Investigación en Sevilla's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free